A Vizuro Company
From Bits to Cures
Unlock the Code of Biology Accelerate Drug Discovery
Evolved by Causal AI & GenAI
Actionable Insights. Faster Development. De-risked Investments.
+ 4X
Faster Discovery Time
Accelerate drug discovery from multiomics analysis, target ranking, drug design and repositioning.
- 8X
Lower Development Cost
Reduce costly trial-and-error with AI predictive insights and in silico simulation to de-risk drug discovery.
+ 3X
Higher Probability of Success
Boost clinical success with AI precision — right targets, patients, indications, and drug candidates.
Ignite Sustainable Innovation
Turn Drugs into new Cures for those in need
Apotek Platform
Systematic prioritization of therapeutic targets, powered by omics
Encode multi-dimensional features to uncover hidden biological signals from large-scale multi-omics data — integrating molecular and clinical evidence to rank and prioritize therapeutic targets with precision.
Solutions
Target Identification
Target
Combining disease profiles across multiomics and cohorts to extract key features and prioritize and clinically relevant targets with composite scores.
Lead Optimization
Drug
Structure-guided generative AI with protein pocket intelligence to perform full-spectrum chemical modifications enabling efficient lead evolution.
Antibody Redesign
Drug
Accelerate therapeutic innovation through faster AI-driven iteration cycles that generate novel antibody sequences with optimized properties.
Indication Prioritization
Indication
Prioritize drug–indication pairs with explainable insights based on knowledge-driven interaction networks informed by biological function and molecular physics.
Drug Repositioning
Indication
Systematic approach to drug asset value creation—leveraging Apotek platform to intelligently reposition existing drugs toward novel indications, de-risk pipeline advancement, and expand patient access to effective therapies.
